Given the important role of RSK in the activation of HSC [10], we hypothesized that a RSK-inhibitory transgenic protein would block phosphorylation of C/EBPβ on Thr217, induce HSC apoptosis and decrease liver fibrosis following chronic liver injury. The gene discussed is CEBPB; the disease is Hepatic fibrosis.